These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 646576)

  • 1. A model for clinical research studies of renal osteodystrophy in children.
    Norman ME; Mazur A; Gruskin AB
    Arch Intern Med; 1978 May; 138 Spec No():866-8. PubMed ID: 646576
    [No Abstract]   [Full Text] [Related]  

  • 2. Questions on the use of vitamin D3.
    Balsan S; Steendijk R
    Pediatrics; 1980 Sep; 66(3):483-4. PubMed ID: 7422447
    [No Abstract]   [Full Text] [Related]  

  • 3. Proceedings: Effect of dihydrotachysterol on azotemic renal osteodystrophy.
    Kawaguchi Y; Sakai S; Ogura Y; Kimura Y; Yamamoto M
    Calcif Tissue Res; 1974; 15(2):160. PubMed ID: 4844400
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of renal osteodystrophy with calciferol (vitamin D) and related steroids.
    Brickman AS; Norman AW
    Kidney Int; 1973 Aug; 4(2):161-7. PubMed ID: 4364427
    [No Abstract]   [Full Text] [Related]  

  • 5. The efficacy of calcifediol in renal osteodystrophy.
    Recker R; Schoenfeld P; Letteri J; Slatopolsky E; Goldsmith R; Brickman A
    Arch Intern Med; 1978 May; 138 Spec No():857-63. PubMed ID: 646574
    [No Abstract]   [Full Text] [Related]  

  • 6. Proceedings: Bone demineralization in renal failure: a longitudinal study of the distal femur using photon absorptiometry.
    Overton TR; Silverberg DS
    AJR Am J Roentgenol; 1976 Jun; 126(6):1289-91. PubMed ID: 179410
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of 1 alpha-(OH)D3 on renal osteodystrophy--a 5-year retrospective evaluation].
    Kakuhara T; Mizoguchi M; Itoh M; Nagasawa M; Mori T; Ohtsuka K; Kubota M; Minatoguchi T; Ohara K; Yoshida M; Koide H; Ohno J
    Nihon Jinzo Gakkai Shi; 1982 Jun; 24(6):693-704. PubMed ID: 7176180
    [No Abstract]   [Full Text] [Related]  

  • 8. Dihydrotachysterol treatment in renal osteodystrophy; the effect on alkaline and acid phosphatase.
    Van Kesteren RG; Duursma SA; Dorhout Mees EJ
    Neth J Med; 1978; 21(1):17-22. PubMed ID: 634412
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of renal osteodystrophy].
    Duursma SA; Dorhout Mees EJ
    Ned Tijdschr Geneeskd; 1978 Mar; 122(11):373-8. PubMed ID: 634388
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapy of renal osteodystrophy with dihydrotachysterol in non-dialyzed patients.
    Teredesai P; Winaver J; Martin LG; Cranley R; Conner TB; Hartsock RJ; Puschett JB
    Clin Nephrol; 1980 Jan; 13(1):31-9. PubMed ID: 7363513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effect of 1alpha-hydroxycholecalciferol in children and adults with renal glomerular osteodystrophy.
    Henderson RG; Kanis JA; Ledingham JG; Oliver DO; Russel RG; Smith R; Walton RJ
    Calcif Tissue Res; 1976 Aug; 21 Suppl():221-5. PubMed ID: 782661
    [No Abstract]   [Full Text] [Related]  

  • 12. [1 alpha-hydroxycholecalciferol in treatment of renal osteodystrophy].
    Chalmers TM; Davie MW; Hunter JO; Szaz KF
    J Urol Nephrol (Paris); 1974 Dec; 80(12):981. PubMed ID: 4617778
    [No Abstract]   [Full Text] [Related]  

  • 13. Vitamin D therapy: problems and prospects.
    Drug Ther Bull; 1975 Apr; 13(8):29-31. PubMed ID: 165927
    [No Abstract]   [Full Text] [Related]  

  • 14. [1 alpha-hydroxycholecalciferol treatment of a 2-year-old child with severe renal osteodystrophy].
    Hansen HE; Christensen MS; Nielsen HE; Johannsen A
    Ugeskr Laeger; 1978 Apr; 140(16):919-21. PubMed ID: 653843
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of dihydrotachysterol in the treatment and prevention of uremic osteopathy in children].
    Sieniawska M; Białasik D
    Pediatr Pol; 1981 Jul; 56(7):733-41. PubMed ID: 7301469
    [No Abstract]   [Full Text] [Related]  

  • 16. The metabolism of vitamin D; recent developments and their clinical relevance.
    Steendijk R
    Neth J Med; 1974; 17(3):131-9. PubMed ID: 4367820
    [No Abstract]   [Full Text] [Related]  

  • 17. 1,25-dihydroxycholecalciferol in renal osteodystrophy. Epiphysiolysis--anticonvulsant therapy.
    Pierides AM; Ellis HA; Dellagrammatikas H; Scott JE; Norman AW
    Arch Dis Child; 1977 Jun; 52(6):464-72. PubMed ID: 879832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptomatic renal osteodystrophy after renal transplantation: treatment with 1-alpha-hydroxycholecalciferol.
    Williams PS; Hillis AN; Carty AJ; Sells RA; Bone JM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2227-8. PubMed ID: 3274500
    [No Abstract]   [Full Text] [Related]  

  • 19. Low-dose vitamin D analogues for renal osteodystrophy.
    Lancet; 1989 Jun; 1(8651):1364-5. PubMed ID: 2567378
    [No Abstract]   [Full Text] [Related]  

  • 20. [Renal osteodystrophy in two children : a comparison of the effects of 1 alpha-hydroxycholecalciferol (author's transl)].
    Chantraine JM; Davin JC; Lambrechts L; Heynen G
    Ann Endocrinol (Paris); 1979; 40(2):161-2. PubMed ID: 475307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.